Dnaprint Genomics Stock Probability of Future Stock Price Finishing Over 0.0
DNAPrint Genomics' future price is the expected price of DNAPrint Genomics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of DNAPrint Genomics performance during a given time horizon utilizing its historical volatility. Check out DNAPrint Genomics Backtesting, DNAPrint Genomics Valuation, DNAPrint Genomics Correlation, DNAPrint Genomics Hype Analysis, DNAPrint Genomics Volatility, DNAPrint Genomics History as well as DNAPrint Genomics Performance. For more detail on how to invest in DNAPrint Stock please use our How to Invest in DNAPrint Genomics guide.The current Price To Sales Ratio is estimated to decrease to 1.49. The current Price Earnings Ratio is estimated to decrease to -0.25. Please specify DNAPrint Genomics' target price for which you would like DNAPrint Genomics odds to be computed.
DNAPrint Genomics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of DNAPrint Genomics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for DNAPrint Genomics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| DNAPrint Genomics generated a negative expected return over the last 90 days | |
| DNAPrint Genomics has some characteristics of a very speculative penny stock | |
| DNAPrint Genomics has a very high chance of going through financial distress in the upcoming years | |
| DNAPrint Genomics currently holds 240 K in liabilities. DNAPrint Genomics has a current ratio of 0.17, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about DNAPrint Genomics' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 2.43 M. Net Loss for the year was (12.35 M) with profit before overhead, payroll, taxes, and interest of 446.37 K. | |
| DNAPrint Genomics currently holds about 134.35 K in cash with (5.78 M) of positive cash flow from operations. | |
| DNAPrint Genomics has a frail financial position based on the latest SEC disclosures |
DNAPrint Genomics Technical Analysis
DNAPrint Genomics' future price can be derived by breaking down and analyzing its technical indicators over time. DNAPrint Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of DNAPrint Genomics. In general, you should focus on analyzing DNAPrint Stock price patterns and their correlations with different microeconomic environments and drivers.
DNAPrint Genomics Predictive Forecast Models
DNAPrint Genomics' time-series forecasting models is one of many DNAPrint Genomics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary DNAPrint Genomics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about DNAPrint Genomics
Checking the ongoing alerts about DNAPrint Genomics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for DNAPrint Genomics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| DNAPrint Genomics generated a negative expected return over the last 90 days | |
| DNAPrint Genomics has some characteristics of a very speculative penny stock | |
| DNAPrint Genomics has a very high chance of going through financial distress in the upcoming years | |
| DNAPrint Genomics currently holds 240 K in liabilities. DNAPrint Genomics has a current ratio of 0.17, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about DNAPrint Genomics' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 2.43 M. Net Loss for the year was (12.35 M) with profit before overhead, payroll, taxes, and interest of 446.37 K. | |
| DNAPrint Genomics currently holds about 134.35 K in cash with (5.78 M) of positive cash flow from operations. | |
| DNAPrint Genomics has a frail financial position based on the latest SEC disclosures |
Check out DNAPrint Genomics Backtesting, DNAPrint Genomics Valuation, DNAPrint Genomics Correlation, DNAPrint Genomics Hype Analysis, DNAPrint Genomics Volatility, DNAPrint Genomics History as well as DNAPrint Genomics Performance. For more detail on how to invest in DNAPrint Stock please use our How to Invest in DNAPrint Genomics guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DNAPrint Genomics. If investors know DNAPrint will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DNAPrint Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of DNAPrint Genomics is measured differently than its book value, which is the value of DNAPrint that is recorded on the company's balance sheet. Investors also form their own opinion of DNAPrint Genomics' value that differs from its market value or its book value, called intrinsic value, which is DNAPrint Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DNAPrint Genomics' market value can be influenced by many factors that don't directly affect DNAPrint Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DNAPrint Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if DNAPrint Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DNAPrint Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.